Lumexa Imaging Holdings (LMRI) insider reports 66,182 shares, 81,081 RSUs

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. reported insider equity activity for its Chief Legal Officer and Corporate Secretary, Julie Szeker, dated December 12, 2025. A transaction coded “M” involved 1,250,000 incentive units of Lumexa Imaging Equity Holdco, LLC tied to 66,182 shares of common stock, which, according to the footnotes, had been converted into stock at the closing of the company’s initial public offering with replacement awards subject to time- and performance-based vesting conditions.

Following the reported activity, Szeker directly beneficially owned 147,263 shares of common stock, including 11,876 shares that vest only if the stock reaches a volume-weighted average price of $24.97 over a 60-trading-day period after the IPO lock-up expires, subject to continued service. She also holds 81,081 restricted stock units, each representing one share of common stock, scheduled to vest in full on December 12, 2026, provided she continues serving the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Szeker Julie

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NC 27609

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer & Corp Sec

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		M		66,182	A	(1)(2)	66,182(3)	D
Common Stock	12/12/2025		A		81,081(4)	A	$0	147,263	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Incentive Units of Holdings LLC(1)(2)	(1)(2)	12/12/2025		M			1,250,000	(1)(2)	(1)(2)	Common Stock	66,182(3)	$0	0	D

Explanation of Responses:

1. Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2]

2. [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO.

3. Includes 11,876 shares of Common Stock that will vest upon the attainment of a prescribed stock price target of $24.97 per share, which target is measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer.

4. Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in full on December 12, 2026, subject to the Reporting Person's continued service with the Issuer.

	/s/ Julie Szeker	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity transaction did Lumexa Imaging Holdings (LMRI) report on December 12, 2025?

The report shows a transaction coded “M” for Chief Legal Officer and Corporate Secretary Julie Szeker involving 1,250,000 incentive units of Lumexa Imaging Equity Holdco, LLC tied to 66,182 shares of common stock, with details explained in the accompanying footnotes.

How many Lumexa Imaging Holdings (LMRI) shares does Julie Szeker own after the reported transactions?

After the reported activity, Julie Szeker beneficially owned 147,263 shares of Lumexa Imaging Holdings common stock in direct ownership.

What are the performance-based vesting conditions for Julie Szeker’s Lumexa Imaging shares?

The filing states that 11,876 shares of common stock will vest only if the stock reaches a $24.97 volume-weighted average closing price per share over any consecutive 60 trading days, with the measurement period starting after the 180-day IPO lock-up, and subject to her continued service.

When do Julie Szeker’s restricted stock units (RSUs) in Lumexa Imaging (LMRI) vest?

The 81,081 RSUs reported each represent the right to receive one share of common stock and are scheduled to vest in full on December 12, 2026, provided Julie Szeker continues her service with the company.

What position does the reporting person hold at Lumexa Imaging Holdings (LMRI)?

The reporting person, Julie Szeker, is an officer of Lumexa Imaging Holdings, serving as Chief Legal Officer & Corporate Secretary.

How are the incentive units referenced in the Lumexa Imaging (LMRI) insider report treated in relation to the IPO?

The footnotes explain that the reported Incentive Units of Lumexa Imaging Equity Holdco, LLC were converted into common stock at the closing of the company’s initial public offering, with shares issued in replacement of unvested units delivered as restricted stock awards subject to time-based and performance-based vesting conditions.